EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $14,464 | -79.9% | 12,258 | +41.1% | 0.00% | – |
| Q1 2022 | $72,000 | +620.0% | 8,685 | +344.9% | 0.00% | – |
| Q4 2021 | $10,000 | -72.2% | 1,952 | -55.8% | 0.00% | – |
| Q3 2020 | $36,000 | +3500.0% | 4,419 | +2109.5% | 0.00% | – |
| Q1 2020 | $1,000 | -66.7% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | – | 200 | +2757.1% | 0.00% | – |
| Q2 2019 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 7 | -65.0% | 0.00% | – |
| Q4 2016 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 20 | -99.4% | 0.00% | -100.0% |
| Q1 2016 | $57,000 | – | 3,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |